Skip to Content

Rebif

In the US, Rebif (interferon beta-1a systemic) is a member of the drug class interferons and is used to treat Multiple Sclerosis.

US matches:

UK matches:

Ingredient matches for Rebif

Interferon Beta

Interferon Beta is reported as an ingredient of Rebif in the following countries:

  • Egypt

Interferon Beta-1A

Interferon Beta-1a is reported as an ingredient of Rebif in the following countries:

  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Finland
  • France
  • Georgia
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Lebanon
  • Lithuania
  • Malaysia
  • Mexico
  • Netherlands
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Tunisia
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide